| P50 | author | Mieczyslaw Litwin | Q57063631 |
| | Jolanta Antoniewicz | Q59210618 |
| | Ryszard Grenda | Q59210629 |
| P2093 | author name string | Joanna Sladowska | |
| P2860 | cites work | The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents | Q22305963 |
| | Angiotensin converting enzyme inhibitor therapy in children with Alport syndrome: effect on urinary albumin, TGF-beta, and nitrite excretion | Q24802921 |
| | Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease | Q28370594 |
| | Late escape from the antiproteinuric effect of ace inhibitors in nondiabetic renal disease | Q32066990 |
| | Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome | Q33360292 |
| | Efficacy and safety of benazepril for advanced chronic renal insufficiency | Q33992851 |
| | The renoprotective effect of combined antihypertensive drugs | Q34203978 |
| | Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy | Q34437499 |
| | Dual blockade of the renin-angiotensin system compared with a 50% increase in the dose of angiotensin-converting enzyme inhibitor: effects on proteinuria and blood pressure | Q34549292 |
| | Congenital nephrotic syndrome: a clinico-pathologic study of thirty children | Q43643808 |
| | Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial | Q44280775 |
| | Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood. | Q44581667 |
| | Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure | Q44978382 |
| | Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders | Q45107648 |
| | Effects of combination treatment with losartan and trandolapril on office and ambulatory blood pressures in non-diabetic renal disease: a COOPERATE-ABP substudy. | Q45140950 |
| | A double-blind, dose-response study of losartan in hypertensive children | Q45308775 |
| | Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria | Q46654200 |
| | Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy. | Q55039366 |
| | Effect of angiotensin-converting enzyme inhibitor therapy on proteinuria in children with renal disease | Q69816942 |
| | Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double-blind trial | Q71181634 |
| | Angiotensin converting enzyme inhibitors and reflux nephropathy: 2-year follow-up | Q74075863 |
| | Risk factors for renal failure in children with non-glomerular nephropathies | Q75193593 |
| P433 | issue | 11 | |
| P921 | main subject | chronic renal insufficiency | Q736715 |
| P304 | page(s) | 1716-1722 | |
| P577 | publication date | 2006-08-15 | |
| P1433 | published in | Pediatric Nephrology | Q15749796 |
| P1476 | title | Add-on therapy with angiotensin II receptor 1 blocker in children with chronic kidney disease already treated with angiotensin-converting enzyme inhibitors | |
| P478 | volume | 21 | |